13 May UPDATE 3-U.S. to consider expanding Medicare drug price negotiation
WASHINGTON/NEW YORK, May 14 (Reuters) – The Trump
administration is considering expanding Medicare’s ability to
negotiate the cost of drugs by giving private payers a role in
setting the price of medicines administered in hospitals and
doctors’ offices, Health and Human Services Secretary Alex Azar
said on Monday.
administration is considering expanding Medicare’s ability to
negotiate the cost of drugs by giving private payers a role in
setting the price of medicines administered in hospitals and
doctors’ offices, Health and Human Services Secretary Alex Azar
said on Monday.
Sorry, the comment form is closed at this time.